Biophytis scores funding

Paris and Cambridge, Massachusetts-based Biophytis, a biotech company that focuses on treating age-related diseases, has raised 6.1 million euros in a private placement.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this